UPC APP 8392/2024

—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
Reps: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Respondents
Roche Diabetes Care GmbH
Reps: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbH)
Division: Paris CD
Judges: Paolo Catallozzi · Presiding Judge / Judge-Rapporteur
Technology: Pharmaceutical & Medical
Language: —
First decided: Feb 20, 2024

Decisions

2024-02-20
Generic application
Order of the Paris Central Division (judge-rapporteur) granting Roche Diabetes Care GmbH's application for extension of the deadline for filing its defence in a non-infringement declaration action brought by Tandem Diabetes Care (EP 2 196 231). Roche had filed a preliminary objection disputing jurisdiction which had not yet been decided; it argued it would be unreasonable to finalise a defence that might become unnecessary. The court extended the deadline to 8 April 2024, finding the extension was justified to await the preliminary objection decision, particularly given the parallel revocation action pending before the same court.
Legal issues:Extension of time for filing defence pending preliminary objectionInteraction between preliminary objection proceedings and main defence deadlineParallel revocation action considerations

Documents